SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-005567
Filing Date
2022-08-11
Accepted
2022-08-11 17:00:49
Documents
55
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_i10q-063022.htm   iXBRL 10-Q 601606
2 SUBLICENSE AGREEMENT xenetic_ex1001.htm EX-10.1 211390
3 LICENSE AGREEMENT xenetic_ex1002.htm EX-10.2 210109
4 SUBSCRIPTION AGREEMENT xenetic_ex1003.htm EX-10.3 143065
5 STATEMENT OF WORK xenetic_ex1004.htm EX-10.4 14692
6 CEO CERTIFICATION xenetic_ex3101.htm EX-31.1 9990
7 CFO CERTIFICATION xenetic_ex3102.htm EX-31.2 10065
8 CERTIFICATION OF EXECUTIVE OFFICERS xenetic_ex3201.htm EX-32.1 4489
9 GRAPHIC a1.jpg GRAPHIC 18721
10 GRAPHIC a2.jpg GRAPHIC 22379
11 GRAPHIC a3.jpg GRAPHIC 1960
  Complete submission text file 0001683168-22-005567.txt   3392937

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE xbio-20220630.xsd EX-101.SCH 22572
13 XBRL CALCULATION FILE xbio-20220630_cal.xml EX-101.CAL 27792
14 XBRL DEFINITION FILE xbio-20220630_def.xml EX-101.DEF 114158
15 XBRL LABEL FILE xbio-20220630_lab.xml EX-101.LAB 176737
16 XBRL PRESENTATION FILE xbio-20220630_pre.xml EX-101.PRE 146843
49 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10q-063022_htm.xml XML 282520
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 221156778
SIC: 2834 Pharmaceutical Preparations